Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
Conclusions: Observational studies on metformin and cancer varied in design, and the majority were at risk of a range of biases. The studies least likely to be affected by bias did not support a causal effect of metformin on cancer risk.
Source: International Journal of Epidemiology - Category: Epidemiology Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Fortamet | Metformin | Statistics | Study